MedPath

Influence of Immobilisation, Stretching and Activity on Morphological and Mechanical Properties of Spastic Muscle

Not Applicable
Active, not recruiting
Conditions
Cerebral Palsy, Spastic
Interventions
Other: Stretching through immobilisation (IG)
Other: Control Phase
Other: Stretching through immobilisation and activity (IAG)
Registration Number
NCT05269745
Lead Sponsor
Medical University of Graz
Brief Summary

Neurologic changes caused by cerebral palsy (CP) result in adaptation of muscle architecture and function (e.g. shortened muscles and contractures). Stretching through immobilization (orthotic treatment) is one of the common interventions to bring the spastic muscle to growth. Positive outcomes of stretching through immobilization are increased range of motion and improved function. On the other hand, immobilization leads to disuse muscle atrophy. Hence, we hypothesize that combining a stretching through immobilization and muscle activity while controlling for foot deformity could be a superior treatment approach, which should lead to improved muscle morphology as well as function. The aim of the study is to examine the influence of two orthotic treatments (a standard regime and one new approach) on spastic plantar flexor muscles in children and adolescents with CP. The standard regime (stretching through immobilisation) includes a dynamic AFO (ankle-foot orthosis) used during day and night. The new approach combines stretching through immobilisation and allows for plantarflexor activity due to an innovative construction of the orthotic device.

This prospective randomized controlled study will recruit 20 ambulant children and adolescents (aged 5 to 15 years) with cerebral palsy and equinus deformity (GMFCS = Gross Motor Function Classification System level I to III). Each child will be randomized and stratified according to age and GMFCS to one of two groups. The first group receives the standard treatment (stretching through immobilization) using custom-made ankle foot orthosis for 23 hours per day. The other group will be treated with the same orthosis at night (8 hours) and for 6 hours during the day but the remaining 10 hours will be treated with the foot shell only that corrects subtalar and Chopart joints but does not block the ankle joint movement, so that more activity of plantarflexors will be possible during the day. The intervention will last for 12 weeks. Each child will be examined at four occasions (8 weeks before intervention = control phase, at the beginning of the intervention and then 8 and 12 weeks later). The main outcome measure is the fascicle length measured using a 3D ultrasound (3DUS) imaging technique. Further parameters of interest span across the whole levels of ICF including clinical examinations, biomechanics of gait, muscle morphologic and mechanic properties and participations questionnaires.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Ambulatory children with spastic CP.
  • Ability to accept and follow verbal instruction.
  • Limited range of motion in ankle joint - maximal dorsiflexion with knee extended ≤ 5°
  • Gross Motor Functional Classification System level I-III.
  • Age 5-15 years.
  • Willingness to participate.
Exclusion Criteria
  • Other than spastic form of CP (ataxic, athetoid or dystonic).
  • Severe mental retardation.
  • Normal range of motion in ankle joint
  • Oral antispastic or muscle relaxing medication.
  • History of orthopaedic surgery in the last 12 months.
  • History of botulinum toxin type A application in the last six months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Immobilization group (IG)Stretching through immobilisation (IG)One group - immobilization group (IG) - will receive the standard treatment.
Control PhaseControl PhaseBefore the intervention with the orthotic treatment starts, a control phase of 8 weeks is planned.
Immobilization/Activity Group (IAG)Stretching through immobilisation and activity (IAG)The other group - Immobilization/Activity Group (IAG) - will be treated with a new approach.
Primary Outcome Measures
NameTimeMethod
Change in mechano-morphological muscle-tendon properties - elongationTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Passive gastrocnemius medialis muscle belly, tendon and muscle-tendon unit elongation due to externally applied torque to the ankle joint \[elongation in mm\]

Change in mechano-morphological muscle-tendon properties - unit lengthTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Gastrocnemius medialis muscle belly, tendon and muscle-tendon unit length

Change in mechano-morphological muscle-tendon properties - fascile lengthTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Gastrocnemius medialis fascile length

Change in joint range of motionTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Ankle joint range of motion (maximal plantarflexion - maximal dorsiflexion)

Change in gait characteristicsTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Gait kinematics (joint angles \[°\]) and kinetics (joint moments \[Nm/kg\]) of the hip, knee, and ankle joints (3D motion capture). Joint angles \[°\] and moments \[Nm/kg\] will be combined to report changes in gait pattern.

Change in mechano-morphological muscle-tendon properties - muscle volumeTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Gastrocnemius medialis muscle volume

Change in mechano-morphological muscle-tendon properties - stiffnessTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Passive gastrocnemius medialis muscle belly, tendon and muscle-tendon unit stiffness due to externally applied torque to the ankle joint \[stiffness in N/mm\]

Change in maximal isometric muscle strengthTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Maximal isometric torque production (isokinetic dynamometry)

Secondary Outcome Measures
NameTimeMethod
Change in self-reported gait, mobility, and functional performance - PODCITime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Pediatrics Outcomes Data Collection Instrument (PODCI) Questionnaire

Change in self-reported gait, mobility, and functional performance - GOALTime Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)

Gait Outcomes Assessment List (GOAL) Questionnaire

Trial Locations

Locations (1)

Medical University Graz

🇦🇹

Graz, Styria, Austria

© Copyright 2025. All Rights Reserved by MedPath